Vitamin D3 Supplementation Guidelines

Introduction to Vitamin D3 Superiority

The American College of Cardiology and other guideline societies recommend cholecalciferol (D3) over ergocalciferol (D2) due to its higher bioefficacy and longer duration of action, with a strength of evidence level of high 1, 2, 3
Cholecalciferol (D3) is preferred over ergocalciferol (D2) for vitamin D deficiency treatment due to higher bioefficacy and longer duration of action, with a moderate to high strength of evidence 2, 3

The National Kidney Foundation's K/DOQI guidelines from 2003 stated that ergocalciferol might be safer than cholecalciferol, although this was based on limited evidence and has been superseded by current guidelines, with a low strength of evidence 4, 5
Older guidelines recommended D2 as the best available treatment for vitamin D deficiency, particularly noting that prescription formulations were ergocalciferol, with a low strength of evidence 4, 5

In the United States, the prescription high-dose formulation (50,000 IU capsules) has historically been available only as ergocalciferol (D2), while D3 was primarily available over-the-counter in lower doses, with a moderate strength of evidence 4, 5
This created a prescribing pattern where physicians writing prescriptions for severe deficiency defaulted to the available D2 formulation, with a moderate strength of evidence 4, 5

For vitamin D deficiency, the recommended dosing is 50,000 IU of cholecalciferol (D3) weekly for 8-12 weeks followed by maintenance therapy of 800-2,000 IU daily, with a high strength of evidence 1, 2, 3
The National Institutes of Health recommends cholecalciferol (D3) over ergocalciferol (D2) due to its longer duration of action and better bioavailability, with a high strength of evidence 2
Target serum 25(OH)D levels should be at least 30 ng/mL for optimal health benefits, with a moderate to high strength of evidence 1, 2, 3

Ensure adequate calcium intake (1,000-1,500 mg daily) alongside vitamin D supplementation, with a moderate strength of evidence 2, 3
Monitor 25(OH)D levels after 3-6 months of supplementation using an assay that measures both 25(OH)D2 and 25(OH)D3, with a moderate strength of evidence 1, 2, 3

Vitamin D supplementation is particularly important for patients with chronic kidney disease, as kidney disease is a major risk factor for deficiency, with a high strength of evidence 1, 3
However, the 2003 K/DOQI guidelines suggested ergocalciferol might be safer in CKD, though this was based on limited evidence and predates current understanding of D3 superiority, with a low strength of evidence 4, 5